483
Dedicated Phase I, Inc.Dedicated Phase I, Inc. – FDA 483, Mar 16, 2012
Record Details
During an inspection, Dedicated Phase I, Inc. was cited for failing to conduct an investigation in accordance with the signed statement of investigator and investigational plan. Specifically, a required blood sample was not taken from a subject during a clinical trial. This indicates a deviation from protocol in a clinical research setting.
View Company Profile
ID · 2252d94c-1945-4069-bff3-5e55ddd691e2
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.